Genmab (GEN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Dk 180.00
   
  • 52 Week High: Dk334.00
  • 52 Week Low: Dk173.50
  • Currency: Denmark Kroner
  • Shares Issued: 44.91m
  • Market Cap: Dk8,083m

Genmab Overview

Genmab is a biotech company developing human antibody therapies and treatments for cancer, rheumatoid arthritis and other diseases.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn n/a
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue n/a
PBT n/a
EPS n/a
DPS n/a

Genmab Fundamentals

Year Ending Revenue (Dkm) Pre-tax (Dkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 135.55 (438.24) (11.26)Dk n/a n/a n/a n/a 0.0%
31-Dec-07 529.54 (383.37) (8.72)Dk n/a n/a n/a n/a 0.0%
31-Dec-08 745.11 (964.51) (21.62)Dk n/a n/a n/a n/a 0.0%
31-Dec-09 586.08 (341.99) (7.75)Dk n/a n/a n/a n/a 0.0%
31-Dec-10 582.08 (122.44) (3.19)Dk n/a n/a n/a n/a 0.0%

Genmab Forecasts

Genmab Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Genmab Market Data

Currency Denmark Kroner
% Change 0.00 %
52 Week High Dk334.00
52 Week Low Dk173.50
Shares Issued 44.91m
Market Cap Dk8,083m

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 2
Sell 1
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page